Hideshi Torii

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Topical Cycling and Systemic Eligibility in Patients With Psoriasis in Japan.

Topical Cycling and Systemic Eligibility in Patients With Psoriasis in Japan.

Journal: The Journal of dermatology

Published: March 31, 2026

Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.

Safety and effectiveness of ixekizumab in Japanese patients with psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis, and erythrodermic psoriasis: Post-marketing surveillance.

Journal: The Journal of dermatology

Published: September 13, 2024

English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.

English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis.

Journal: The Journal of dermatology

Published: March 01, 2023

English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).

English version of Japanese guidance for use of biologics for psoriasis (the 2022 version).

Journal: The Journal of dermatology

Published: November 25, 2022

Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.

Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.

Journal: The Journal of dermatology

Published: February 28, 2022

Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies.

Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies.

Journal: Journal of drugs in dermatology : JDD

Published: April 14, 2021

Japanese guidance for use of biologics for psoriasis (the 2019 version).

Japanese guidance for use of biologics for psoriasis (the 2019 version).

Journal: The Journal of dermatology

Published: November 23, 2019

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials.

Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials.

Journal: Dermatology and therapy

Published: August 30, 2019

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure.

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure.

Journal: Dermatology and therapy

Published: August 08, 2019

Case of systemic lupus erythematosus with strong proteinase 3 antineutrophil cytoplasmic antibody positivity.

Case of systemic lupus erythematosus with strong proteinase 3 antineutrophil cytoplasmic antibody positivity.

Journal: The Journal of dermatology

Published: March 08, 2019

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.

Tofacitinib for the treatment of moderate to severe chronic plaque psoriasis in Japanese patients: Subgroup analyses from a randomized, placebo-controlled phase 3 trial.

Journal: The Journal of dermatology

Published: February 07, 2017

Case of sarcoidosis with seasonal cutaneous ulceration.

Case of sarcoidosis with seasonal cutaneous ulceration.

Journal: The Journal of dermatology

Published: November 19, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026